{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:09:33Z","timestamp":1790831373162,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clim.2019.108322","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T12:31:46Z","timestamp":1575894706000},"page":"108322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["Juvenile idiopathic arthritis-associated uveitis"],"prefix":"10.1016","volume":"211","author":[{"given":"Ethan S.","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2019.108322_bb0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2015.20","article-title":"Uveitis associated with juvenile idiopathic arthritis","volume":"11","author":"Sen","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.berh.2018.01.002","article-title":"Juvenile idiopathic arthritis-associated uveitis","volume":"31","author":"Sen","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group, Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273940801899822","article-title":"International Uveitis Study Group (IUSG): clinical classification of uveitis","volume":"16","author":"Deschenes","year":"2008","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0025","series-title":"Pediatric Rheumatology - A Clinical Viewpoint","first-page":"623","article-title":"Uveitis in children","author":"Sen","year":"2017"},{"key":"10.1016\/j.clim.2019.108322_bb0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-005-0087-3","article-title":"Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature","volume":"244","author":"Carvounis","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0035","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2019.108322_bb0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/annrheumdis-2019-eular.8744","article-title":"A phase II single arm (adaptive design) trial of tocilizumab in anti-TNF refractory patients with juvenile idiopathic arthritis-associated uveitis (APTITUDE trial)","volume":"78","author":"Ramanan","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108322_bb0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0420.2000.078001084.x","article-title":"Uveitis in children: population-based study in Finland","volume":"78","author":"Paivonsalo-Hietanen","year":"2000","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.clim.2019.108322_bb0050","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3899\/jrheum.130302","article-title":"Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry","volume":"40","author":"Angeles-Han","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0055","doi-asserted-by":"crossref","first-page":"461078","DOI":"10.1155\/2014\/461078","article-title":"The role of gender in juvenile idiopathic arthritis-associated uveitis","volume":"2014","author":"Moradi","year":"2014","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S2352-4642(19)30027-6","article-title":"Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study","volume":"3","author":"Consolaro","year":"2019","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.clim.2019.108322_bb0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12969-017-0195-8","article-title":"Nordic study Group of Pediatric Rheumatology (NoSPeR), incidence and predictors of uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study","volume":"15","author":"Nordal","year":"2017","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.clim.2019.108322_bb0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaapos.2008.03.007","article-title":"Course, complications, and outcome of juvenile arthritis-related uveitis","volume":"12","author":"Sabri","year":"2008","journal-title":"J. AAPOS"},{"key":"10.1016\/j.clim.2019.108322_bb0075","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ICU.0b013e32833eab83","article-title":"Juvenile idiopathic arthritis-associated uveitis","volume":"21","author":"Qian","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0080","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/09273948.2013.791701","article-title":"Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors","volume":"21","author":"Heiligenhaus","year":"2013","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12969-015-0018-8","article-title":"Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis","volume":"13","author":"Angeles-Han","year":"2015","journal-title":"Pediatr. Rheum. Online J."},{"key":"10.1016\/j.clim.2019.108322_bb0090","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/art.40544","article-title":"Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with juvenile idiopathic arthritis study","volume":"70","author":"Tappeiner","year":"2018","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108322_bb0095","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.27416","article-title":"Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis","volume":"62","author":"Saurenmann","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108322_bb0100","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/acr.23783","article-title":"Prospective determination of the incidence and risk factors of new-onset uveitis in juvenile idiopathic arthritis: the research in arthritis in Canadian children emphasizing outcomes cohort","volume":"71","author":"Lee","year":"2019","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.clim.2019.108322_bb0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/09273948.2013.841495","article-title":"Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis","volume":"22","author":"Pelegr\u00edn","year":"2014","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/09273941003678837","article-title":"Uveitis related to juvenile idiopathic arthritis: familial cases and possible genetic implication in the pathogenesis","volume":"18","author":"Juli\u00e1n","year":"2010","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0115","first-page":"1","article-title":"Pathophysiology of JIA-associated uveitis","author":"Vastert","year":"2014","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0120","first-page":"1394","article-title":"Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis","volume":"18","author":"Giannini","year":"1991","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3476(05)82541-7","article-title":"Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis","volume":"121","author":"Melin-Aldana","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2019.108322_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09273940902999356","article-title":"Immune response genes in uveitis","volume":"17","author":"Du","year":"2009","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/eye.2011.255","article-title":"Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation","volume":"26","author":"Lee","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clim.2019.108322_bb0140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.survophthal.2014.03.002","article-title":"Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown","volume":"59","author":"Kalinina Ayuso","year":"2014","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0145","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2019.108322_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12016-011-8267-x","article-title":"Cutting-edge issues in autoimmune uveitis","volume":"41","author":"Levy","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2019.108322_bb0155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/jaut.1996.0077","article-title":"Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease","volume":"9","author":"Nussenblatt","year":"1996","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2019.108322_bb0160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2019.108322_bb0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/09273948.2012.681830","article-title":"Treg lymphocytes in autoimmune uveitis","volume":"20","author":"Ruggieri","year":"2012","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2019.03.004","article-title":"Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis","volume":"100","author":"Wildschutz","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2019.108322_bb0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.22381","article-title":"Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study","volume":"56","author":"Saurenmann","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108322_bb0180","first-page":"1074","article-title":"Antibodies to iris and retina detected in sera from patients with juvenile rheumatoid arthritis with iridocyclitis by indirect immunofluorescence studies on human eye tissue","volume":"16","author":"Uchiyama","year":"1989","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0185","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3389\/fimmu.2019.01793","article-title":"Identification of ocular autoantigens associated with juvenile idiopathic arthritis-associated uveitis","volume":"10","author":"Busch","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2019.108322_bb0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.exer.2007.06.011","article-title":"Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis","volume":"85","author":"Sijssens","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.clim.2019.108322_bb0195","doi-asserted-by":"crossref","unstructured":"T. Constantin, I. Foeldvari, J. Anton, J. de Boer, S. Czitrom-Guillaume, C. Edelsten, R. Gepstein, A. Heiligenhaus, C.A. Pilkington, G. Simonini, Y. Uziel, S.J. Vastert, N.M. Wulffraat, A.M. Haasnoot, K. Walscheid, A. Palinkas, R. Pattani, Z. Gyorgyi, R. Kozma, V. Boom, A. Ponyi, A. Ravelli, A.V. Ramanan, Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative, Ann. Rheum. Dis., 77 (2018) 1107-1117.","DOI":"10.1136\/annrheumdis-2018-213131"},{"key":"10.1016\/j.clim.2019.108322_bb0200","article-title":"Guidelines for screening for uveitis in juvenile idiopathic","author":"British Society for Paediatric and Adolescent Rheumatology","year":"2006","journal-title":"Arthritis"},{"key":"10.1016\/j.clim.2019.108322_bb0205","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","article-title":"Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines","volume":"46","author":"Heiligenhaus","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108322_bb0210","series-title":"Screening for Uveitis in Children with Juvenile Idiopathic Arthritis (JIA)","article-title":"Best evidence statement (BESt)","author":"National Guideline Clearinghouse","year":"2012"},{"key":"10.1016\/j.clim.2019.108322_bb0215","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1542\/peds.2006-0421","article-title":"Ophthalmologic examinations in children with juvenile rheumatoid arthritis","volume":"117","author":"Cassidy","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.clim.2019.108322_bb0220","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/acr.23871","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.clim.2019.108322_bb0225","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/rheumatology\/kep460","article-title":"BSPAR standards of care for children and young people with juvenile idiopathic arthritis","volume":"49","author":"Davies","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108322_bb0230","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1111\/j.1755-3768.2011.02162.x","article-title":"Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis","volume":"89","author":"Tappeiner","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0235","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bjophthalmol-2011-300731","article-title":"Elevated intraocular pressure in uveitis associated with juvenile idiopathic arthritis-associated uveitis, often detected after achieving inactivity","volume":"96","author":"Heinz","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-016-0088-2","article-title":"Juvenile idiopathic arthritis-associated uveitis","volume":"14","author":"Clarke","year":"2016","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.clim.2019.108322_bb0245","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/acr.21674","article-title":"Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood","volume":"64","author":"Heiligenhaus","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.clim.2019.108322_bb0250","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","article-title":"Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus","volume":"35","author":"Bou","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2019.108322_bb0255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.survophthal.2015.10.005","article-title":"Managing juvenile idiopathic arthritis-associated uveitis","volume":"61","author":"Hawkins","year":"2016","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0260","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2019.108322_bb0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semarthrit.2018.11.004","article-title":"Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"49","author":"Heiligenhaus","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108322_bb0270","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-014-0437-4","article-title":"Treatment of uveitis associated with juvenile idiopathic arthritis","volume":"16","author":"Bou","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.clim.2019.108322_bb0275","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.autrev.2010.05.017","article-title":"Current therapeutic approaches to autoimmune chronic uveitis in children","volume":"9","author":"Simonini","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2019.108322_bb0280","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.108322_bb0285","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","article-title":"Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach","volume":"52","author":"Simonini","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108322_bb0290","first-page":"92","article-title":"Uveitis in juvenile idiopathic arthritis","volume":"112","author":"Heiligenhaus","year":"2015","journal-title":"Deutsches Arzteblatt Int."},{"key":"10.1016\/j.clim.2019.108322_bb0295","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12969-017-0189-6","article-title":"Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis","volume":"15","author":"Sen","year":"2017","journal-title":"Pediatr. Rheum. Online J."},{"key":"10.1016\/j.clim.2019.108322_bb0300","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","article-title":"Methotrexate--how does it really work?","volume":"6","author":"Chan","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0305","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bjo.2009.173542","article-title":"Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis","volume":"95","author":"Goebel","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0310","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bjo.2006.094698","article-title":"Mycophenolate mofetil in the treatment of uveitis in children","volume":"91","author":"Doycheva","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0315","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/eye.2011.23","article-title":"Mycophenolate mofetil monotherapy in the management of paediatric uveitis","volume":"25","author":"Chang","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clim.2019.108322_bb0320","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ophtha.2007.12.011","article-title":"Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis","volume":"115","author":"Sobrin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.108322_bb0325","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/eye.2008.174","article-title":"Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis","volume":"23","author":"Tappeiner","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clim.2019.108322_bb0330","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjo.82.7.737","article-title":"Cyclosporin A therapy in refractory non-infectious childhood uveitis","volume":"82","author":"Kilmartin","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0335","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ophtha.2007.01.026","article-title":"Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis","volume":"114","author":"Hogan","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.108322_bb0340","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/archdischild-2013-304396","article-title":"New age of biological therapies in paediatric rheumatology","volume":"99","author":"Sen","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.clim.2019.108322_bb0345","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acr.22214","article-title":"Current evidence of anti-tumor necrosis factor \u03b1 treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs","volume":"66","author":"Simonini","year":"2014","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.clim.2019.108322_bb0350","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108322_bb0355","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3899\/jrheum.130133","article-title":"High doses of infliximab in the management of juvenile idiopathic arthritis","volume":"40","author":"Tambralli","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0360","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2017-212089","article-title":"ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis","volume":"77","author":"Quartier","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108322_bb0365","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12348-012-0081-y","article-title":"Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis","volume":"2","author":"William","year":"2012","journal-title":"J. Ophthalmic. Inflamm. Infect."},{"key":"10.1016\/j.clim.2019.108322_bb0370","first-page":"652","article-title":"Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review","volume":"36","author":"Palmou-Fontana","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0375","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3899\/jrheum.160231","article-title":"Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis","volume":"43","author":"Tappeiner","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0380","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/art.39940","article-title":"Anti-interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients","volume":"69","author":"Calvo-R\u00edo","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108322_bb0385","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41927-018-0010-2","article-title":"A phase II trial protocol of tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)","volume":"2","author":"Ramanan","year":"2018","journal-title":"BMC Rheum."},{"key":"10.1016\/j.clim.2019.108322_bb0390","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20115","article-title":"Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis","volume":"62","author":"Zulian","year":"2010","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.clim.2019.108322_bb0395","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00417-010-1523-6","article-title":"Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis","volume":"249","author":"Kenawy","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0400","author":"Suhler"},{"key":"10.1016\/j.clim.2019.108322_bb0405","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.140410","article-title":"Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis","volume":"42","author":"Tappeiner","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0410","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3899\/jrheum.151389","article-title":"Comparable efficacy of abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis","volume":"43","author":"Birolo","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0415","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/rheumatology\/ker107","article-title":"Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)","volume":"50","author":"Heiligenhaus","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108322_bb0420","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ophtha.2010.07.031","article-title":"Rituximab for uveitis","volume":"118","author":"Miserocchi","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.108322_bb0425","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","article-title":"Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis","volume":"100","author":"Miserocchi","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00417-016-3497-5","article-title":"Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis","volume":"255","author":"Breitbach","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0435","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/archdischild-2018-315060","article-title":"Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis","volume":"104","author":"Skrabl-Baumgartner","year":"2019","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.clim.2019.108322_bb0440","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.2006.058248","article-title":"Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis","volume":"66","author":"Tynj\u00e4l\u00e4","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108322_bb0445","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108322_bb0450","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2006.08.044","article-title":"Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents","volume":"149","author":"Saurenmann","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2019.108322_bb0455","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108322_bb0460","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/acr.20404","article-title":"Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab","volume":"63","author":"Simonini","year":"2011","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.clim.2019.108322_bb0465","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/eye.2009.203","article-title":"Switching biologic agents for uveitis","volume":"23","author":"Dhingra","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clim.2019.108322_bb0470","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3899\/jrheum.120010","article-title":"Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?","volume":"39","author":"Tappeiner","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0475","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/09273948.2013.866254","article-title":"Tocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patient","volume":"22","author":"Tsang","year":"2014","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0480","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/annrheumdis-2013-203523","volume":"73","author":"Burmester","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108322_bb0485","series-title":"ClinicalTrials.gov","author":"Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Polyarticular-Course and Systemic Juvenile Idiopathic Arthritis","year":"2017"},{"key":"10.1016\/j.clim.2019.108322_bb0490","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3899\/jrheum.160908","article-title":"Subcutaneous tocilizumab may be less effective than intravenous tocilizumab in the treatment of juvenile idiopathic arthritis-associated uveitis","volume":"44","author":"Quesada-Masachs","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0495","first-page":"1","article-title":"Effect of Janus kinase inhibitor treatment on anterior uveitis and associated macular edema in an adult patient with juvenile idiopathic arthritis","author":"Bauermann","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0500","series-title":"ClinicalTrials.gov","author":"An Open-label, Active-Controlled, Safety, aand Efficacy Study of Oral Baricitinib in Patients FFrom 2 Years to Less TThan 1818 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis","year":"2019"},{"key":"10.1016\/j.clim.2019.108322_bb0505","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2015.04.016","article-title":"Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors","volume":"160","author":"Lerman","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0510","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/09273948.2018.1424341","article-title":"Relapse of juvenile idiopathic arthritis-associated uveitis after discontinuation of immunomodulatory therapy","volume":"27","author":"Acharya","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0515","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3899\/jrheum.161336","article-title":"Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis","volume":"44","author":"Simonini","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108322_bb0520","author":"Acharya"},{"key":"10.1016\/j.clim.2019.108322_bb0525","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/14740338.2015.1042453","article-title":"Safety of biologic therapies for the treatment of juvenile idiopathic arthritis","volume":"14","author":"Horneff","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.clim.2019.108322_bb0530","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/acr.22613","article-title":"Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry","volume":"67","author":"Foeldvari","year":"2015","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.clim.2019.108322_bb0535","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/rheumatology\/keu457","article-title":"Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting","volume":"54","author":"Tarkiainen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108322_bb0540","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","article-title":"Systemic immunosuppressive therapy for eye diseases cohort study research group, risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the systemic immunosuppressive therapy for eye diseases study","volume":"120","author":"Gregory","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clim.2019.108322_bb0545","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09273940802650398","article-title":"Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study","volume":"17","author":"Skarin","year":"2009","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clim.2019.108322_bb0550","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/ard.2004.026955","article-title":"Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients","volume":"64","author":"Kotaniemi","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108322_bb0555","article-title":"Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis","volume":"8","author":"Angeles-Han","year":"2013","journal-title":"Int. J. Clin. Rheum."},{"key":"10.1016\/j.clim.2019.108322_bb0560","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0002-9394(03)00225-3","article-title":"Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program","volume":"135","author":"Chia","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0565","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.86.1.51","article-title":"An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood","volume":"86","author":"Edelsten","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0570","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ajo.2010.01.014","article-title":"Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis","volume":"149","author":"Kalinina Ayuso","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1755-3768.2009.01815.x","article-title":"Timing of uveitis onset in oligoarticular juvenile idiopathic arthritis (JIA) is the main predictor of severe course uveitis","volume":"90","author":"Zannin","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.clim.2019.108322_bb0580","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/rheumatology\/key406","article-title":"Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study","volume":"58","author":"Heiligenhaus","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108322_bb0585","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00281-014-0433-9","article-title":"Autoimmune and autoinflammatory mechanisms in uveitis","volume":"36","author":"Lee","year":"2014","journal-title":"Semin. Immunopathol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619305303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619305303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:00:14Z","timestamp":1761494414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661619305303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":117,"alternative-id":["S1521661619305303"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2019.108322","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile idiopathic arthritis-associated uveitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2019.108322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108322"}}